Tylosin,mixt. with 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide and (11â)-11,17,21-trihydroxypregna- 1,4-diene-3,20-dione (93746-31-7)

Identification
Name:	Tylosin,mixt. with 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide and (11â)-11,17,21-trihydroxypregna- 1,4-diene-3,20-dione
CAS:	93746-31-7
Molecular Formula:	C46H77NO17.C21H28O5.C11H12Cl2N2O5
Molecular Structure:
Properties
Safety Data

Other Product

Pregna-1,4-diene-3,20-dione,9-fluoro-11,17,- 21-trihydroxy-16-methyl-,(11â,16R)-,mixt. with 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide
Tylosin,(2R,3R)-2,3-dihydroxybutanedioate (salt),mixt. with 21-(acetyloxy)-17-hydroxypregna-1,4-diene- 3,11,20-trione and 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide
Pregna-1,4-diene-3,20-dione,21-(2,2- dimethyl-1-oxopropoxy)-9-fluoro-11,17- dihydroxy-16-methyl-,(11â,16R)-,mixt. with (11â)-11,17,21-trihydroxypregna-1,4-diene-3,- 20-dione
Acetamide,2,2-dichloro-N-[(1R,2R)-2- hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)- ethyl]-,mixt. with 4,4'-sulfonylbis[benzenamine]
Pregna-1,4-diene-3,20-dione,21-(acetyloxy)- 9-fluoro-11,17-dihydroxy-16-methyl-,(11â,- 16R)-,mixt. with (11â)-11,17,21-trihydroxypregna-1,4-diene-3,- 20-dione
Acetamide,2,2-dichloro-N-[(1R,2R)-2- hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)- ethyl]-,mixt. with 2-(diethylamino)-N-(2,4,6-trimethylphenyl)- acetamide
Nystatin,mixt. with 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide and 2-methyl-5-nitro-1Himidazole- 1-ethanol
Pregna-1,4-diene-3,20-dione,9-fluoro-11,17,- 21-trihydroxy-16-methyl-,(11â,16â)-,mixt. with N,N-dimethyl-3-[1-(2-pyridinyl)ethyl]- 1H-indene-2-ethanamine (2Z)-2-butenedioate (1:1)
Pregna-1,4-diene-3,20-dione,21-[2-(4-cyclohexylphenyl)- 1-oxobutoxy]-11,17-dihydroxy-,(11â)-
Acetamide,2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-,rel-
Pregna-1,4-diene-3,20-dione,6-fluoro-11,17,- 21-trihydroxy-,(6R,11â)-,mixt. with 4,5-dihydro-2-(1-naphthalenylmethyl)-1Himidazole and (RR)-R-[(1S)-1-(methylamino)- ethyl]benzenemethanol
2-bromo-6β-fluoro-5α,17,21-trihydroxypregna-1,4(11)-diene-3,20-dione 21-acetate
6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,- 16,18,20-pentaene-25-carboxylic acid,22-[(3-amino-3,6-dideoxy-â-Dmannopyranosyl) oxy]-1,3,26-trihydroxy-12- methyl-10-oxo-,(1R,3S,5R,7R,8E,12R,14E,- 16E,18E,20E,22R,24S,25R,26S)-,mixt. with 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide
Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
Acetamide,2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl-2,3,5,6-d4)ethyl-2-d]-(9CI)
Acetamide,N-[(1R,2R)-2-(acetyloxy)-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-2,2-dichloro-
Acetamide,N-[(1R,2R)-2-(acetyloxy)-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-2,2-dichloro-
Pregna-3,5-diene-6-carboxaldehyde,21- (acetyloxy)-3-(2-chloroethoxy)-9-fluoro-11- hydroxy-16,17-[(1-methylethylidene)bis(oxy)]- 20-oxo-,(11â,16R)-,mixt. with O-2-amino-2-deoxy-R-D-glucopyranosyl- (1f4)-O-[O-2,6-diamino-2,6-dideoxy-â-Lidopyranosyl-( 1f3)-â-D-ribofuranosyl- (1f5)]-2-deoxy-D-streptamine sulfate (salt)
Benzoic acid,4-amino-,ethyl ester,mixt. with rel-2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide and 2-[(5-nitro-2-furanyl)methylene] hydrazinecarboxamide